This consultation concerns the supply of drugs the direct purchase of which is authorized by the public health code within the framework of the missions of the Departmental Council. It is more particularly about:
- drugs intended for the treatment of tuberculosis patients or patients suffering from a sexually transmitted infection (excluding HIV);
- emergency or demonstration drugs as part of medical consultation activities;
- oral contraceptives.
Lot nº 1: various medicinesVarious drugs.
Lot nº 2: vitamin-DVitamin D.
Lot nº 3: oral contraceptive Levonorgestrel 1.5 mgOral contraceptive Levonorgestrel 1.5 mg.
Lot nº 4: oral contraceptive tri-phasic combination ethinylestradiol 30/40/30 μg + levonorgestrel 50/75/125 μgOral contraceptive tri-phasic combination ethinylestradiol 30/40/30 μg + levonorgestrel 50/75/125 μg.
Lot no. 5: oral contraceptive mono-phasic combination ethinylestradiol 30 μg + levonorgestrel 150 μgOral contraceptive mono-phasic combination ethinylestradiol 30 μg + levonorgestrel 150 μg.
Lot nº 6: oral contraceptive two-phase combination ethinylestradiol 30/40 μg + levonorgestrel 150/200 μgOral contraceptive two-phase combination ethinylestradiol 30/40 μg + levonorgestrel 150/200 μg.
Lot nº 7: oral contraceptive mono-phasic combination ethinylestradiol 20 μg + levonorgestrel 100 μgOral contraceptive mono-phasic combination ethinylestradiol 20 μg + levonorgestrel 100 μg.
Lot nº 8: oral contraceptive Levonorgestrel 30 μgOral contraceptive Levonorgestrel 30 μg.
Lot nº 9: oral contraceptive ethinylestradiol 20 μg + levonorgestrel 100 μgOral contraceptive ethinylestradiol 20 μg + levonorgestrel 100 μg.